143 episodes
Foundation Fighting Blindness Fnd Fighting Blindness
-
- Science
-
-
5.0 • 15 Ratings
-
The Foundation Fighting Blindness is committed to finding treatments and cures for blinding retinal diseases that affect more than 10 million people in the United States. To learn more, go to FightingBlindness.org.
-
ARVO 2024 Highlight: InGel’s Cell Therapy Shows Promise for Preserving Vision
The emerging treatment is designed to work for people with RP and other conditions regardless of the gene mutation causing disease
-
ARVO 2024 Highlight: PYC Reports Initial Clinical Trial Results for its RNA Therapy Targeting RP
No serious adverse events were reported. One patient had encouraging improvement in retinal sensitivity.
-
ARVO 2024 Highlight: New Gene Linked to RP in People with African Ancestry
The discovery will help geneticists diagnose more RP patients with African descent.
-
ARVO 2024 Highlight: Positive Two-Year Results from PDE6B Gene Therapy Clinical Trial
Mutations in PDE6B are a leading cause of retinitis pigmentosa.
-
Eye on the Cure Podcast | Episode 65: Matthew Whitaker
Matthew Whitaker talks to host Ben Shaberman about his remarkable achievements and success as a young jazz pianist and composer. Matthew was born three months prematurely and weighed less than two pounds. The oxygen he needed to stay alive also caused total blindness. But now 23 years old, the renowned music prodigy has recorded four albums, received several honors and awards, and appeared on TV shows such as Showtime at the Apollo, the Today Show, Ellen, and 60 Minutes.
-
Atsena’s XLRS Gene Therapy Shows Efficacy in Phase 1/2 Clinical Trial
The XLRS gene therapy was well tolerated and resolved damaging schisis cavities in patients receiving the lowest dose.